Loading...
XASX
VIT
Market cap8mUSD
Oct 09, Last price  
0.02AUD
1D
0.00%
1Q
-32.14%
IPO
-94.72%
Name

Vitura Health Ltd

Chart & performance

D1W1MN
XASX:VIT chart
P/E
—
P/S
0.10
EPS
—
Div yield, %
10.53%
Shrs. gr., 5y
10.53%
Rev. gr., 5y
43.29%
Revenues
131m
+5.74%
18,000447,5940123,85021,712,16666,991,732117,343,633123,870,868124,036,970131,158,015
Net income
-4m
L
-22,341150,349-2,914,301-3,937,213-4,049,2096,048,53413,809,3893,512,3783,324,321-4,392,015
CFO
-91k
L
-20,465253,349-1,657,739-4,889,8031,067,98413,504,6699,708,3256,997,4012,667,677-91,024
Dividend
Sep 05, 20250.002 AUD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 2018 and based in South Yarra, Australia, Vitura Health Limited focuses on the supply and marketing of medicinal cannabis goods throughout Australia and the Asian market. The company manages a portfolio of key brands, such as CanView, Burleigh Heads Cannabis, CDA Clinics, Cannadoc, and Adaya. This entity was formerly recognized as Cronos Australia Limited before adopting the name Vitura Health Limited in February 2023.
IPO date
Nov 07, 2019
Employees
Domiciled in
AU
Incorporated in
AU
Headquarters & legal address
Suite 8, Level 3
299 Toorak Road
South Yarra, VIC 3141
AU
Previous name
Cronos Australia Limited

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑062025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT